dabigatran vs darunavir
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of dabigatran and darunavir. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
dabigatran etexilate edoxaban ↑ dabigatran ↑ edoxaban Refer to the dabigatran etexilate or edoxaban prescribing information for recommendations regarding co-administration. The specific recommendations are based on indication, renal function, and effect of the co-administered P-gp inhibitors on the concentration of dabigatran or edoxaban. Clinical monitoring is recommended when a DOAC not affected by CYP3A4 but transported by P-gp, including dabigatran etexilate and edoxaban, is co-administered with darunavir /ritonavir.
Pradaxa
Prezista
Dabigatran (Pradaxa) is a drug that helps to prevent blood clots from forming. It is used to lower the risk of stroke and treat or prevent other dangerous clots in your body.
Darunavir is a medicine used to treat HIV. It belongs to a class of drugs called protease inhibitors and must be taken with ritonavir.
This medicine can help prevent strokes in people with an irregular heartbeat called atrial fibrillation. It can also treat blood clots in your legs (deep vein thrombosis or DVT) or lungs (pulmonary embolism or PE). Dabigatran can also lower the risk of these clots coming back. It is also used to prevent blood clots after hip replacement surgery.
Darunavir is used to treat HIV-1 infection in adults and children 3 years and older. It must be taken with ritonavir and other HIV medicines. Darunavir helps to lower the amount of HIV in your body.
Dabigatran is a direct thrombin inhibitor. Thrombin is a substance in the blood that helps clots form. By blocking thrombin, dabigatran helps to keep your blood from clotting too easily.
Darunavir is a protease inhibitor. It works by blocking an enzyme called protease that HIV needs to make copies of itself. This helps to slow down the spread of HIV in your body.
- • Upset stomach
- • Bleeding more easily (such as nosebleeds or heavier periods)
- • Diarrhea
- • Nausea
- • Rash
- • Headache
- • Abdominal pain
No adverse event reports.
- Foetal Exposure During Pregnancy 1,150
- Drug Interaction 981
- Pain 889
- Emotional Distress 812
- Anxiety 811
Dabigatran has two important warnings. First, stopping this medicine too early can raise your risk of blood clots. Do not stop taking it without talking to your doctor. Second, this medicine can cause bleeding around the spine if you get an epidural or spinal tap. This can lead to paralysis. Tell your doctor if you are going to have any spinal procedures.
Darunavir can cause liver problems. Your doctor should check your liver before you start taking darunavir and during treatment. Tell your doctor right away if you have any signs of liver problems, such as yellowing of the skin or eyes.
Talk to your doctor if you are pregnant or plan to become pregnant. Dabigatran may increase the risk of bleeding in the fetus. Breastfeeding is not recommended while taking this medicine.
Tell your doctor if you are pregnant or plan to become pregnant. The recommended dose during pregnancy is 600 mg twice daily with ritonavir 100mg and food. Women with HIV should not breastfeed because HIV can be passed to the baby through breast milk.
How to Read This dabigatran vs darunavir Comparison
dabigatran is classified in the Direct Thrombin Inhibitor drug class, while darunavir sits within the HIV Protease Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, dabigatran has 0 submissions while darunavir has 4,643. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to darunavir blocks a protein that helps remove dabigatran from the body, which can lead to higher levels of the blood thinner in your system.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for dabigatran or darunavir.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.